Simplex Trading, LLC Ampio Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.42 - $0.62 $2,608 - $3,850	-6,210 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$0.56 - $1.71 $82,552 - $252,081	-147,416 Reduced 95.96%	6,210 $3,000
Q2 2021 Aug 12, 2021	SELL	$1.56 - $1.98 $59,373 - $75,358	-38,060 Reduced 19.86%	153,626 $256,000
Q1 2021 Apr 26, 2021	BUY	$1.36 - $2.49 $201,573 - $369,057	148,216 Added 340.96%	191,686 $323,000
Q4 2020 Feb 02, 2021	BUY	$0.75 - $2.76 $32,602 - $119,977	43,470 New	43,470 $69,000
Q4 2019 Feb 05, 2020	SELL	$0.35 - $0.58 $105 - $174	-300 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$0.38 - $0.52 $114 - $156	300 New	300 $0
Q2 2018 Jul 30, 2018	SELL	$1.66 - $3.82 $20,461 - $47,085	-12,326 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$2.16 - $3.48 $26,306 - $42,382	12,179 Added 8285.03%	12,326 $41,000
Q4 2017 Jan 10, 2018	SELL	$0.68 - $4.19 $2,212 - $13,630	-3,253 Reduced 95.68%	147 $0
Q3 2017 Oct 25, 2017	BUY	$0.38 - $0.66 $1,292 - $2,244	3,400	3,400 $2,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.